DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Garber JE, Halabi S, Tolaney SM. et al; Cancer and Leukemia Group B.
Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.
J Natl Cancer Inst 2010;
102 (13) 942-949
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.